Live from the NIH registry
Studies recruiting near Fairfield right now
Top 25 of 345 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Northbay Cancer Center — Vacaville, California (7.2 mi)
· Sponsor: SWOG Cancer Research Network
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Walnut Creek, California (24.4 mi)
· Sponsor: AstraZeneca
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
John Muir Physician Network Clin. Research Center — Walnut Creek, California (24.4 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (24.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Bay Area Retina Associates - Walnut Creek — Walnut Creek, California (24.4 mi)
· Sponsor: Boehringer Ingelheim
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Alcohol-ROC-Training
Binge Drinking, Heavy Drinking
N/A
Interventional 177 participants sought
University of California, Berkeley — Berkeley, California (29.7 mi)
· Sponsor: Yale University
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
Bay Area Retina Associates — Walnut Creek, California (24.4 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Sunwise Clinical Research /ID# 270431 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Sutter Solano Medical Center/Cancer Center — Vallejo, California (16.1 mi)
· Sponsor: NRG Oncology
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
Dry Eye, Meibomian Gland Dysfunction
Phase 4
Interventional 65 participants sought
U.C. Berkeley Clinical Research Center — Berkeley, California (29.7 mi)
· Sponsor: University of California, Berkeley
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kaiser Permanente - Vallejo Medical Center — Vallejo, California (16.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Alta Bates Summit Medical Center ( Site 0004) — Berkeley, California (29.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
John Muir Medical Center /ID# 257103 — Concord, California (19.4 mi)
· Sponsor: AbbVie
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Walnut Creek, California (24.4 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Sunwise Clinical Research /ID# 248529 — Walnut Creek, California (24.4 mi)
· Sponsor: AbbVie
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Degenerative Disc Disease (DDD)
N/A
Interventional 225 participants sought
Boomerang Healthcare (IPM Medical Group) — Walnut Creek, California (24.4 mi)
· Sponsor: ReGelTec, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente Vallejo Medical Center ( Site 0060) — Vallejo, California (16.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-067 — Walnut Creek, California (24.4 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Contra Costa Regional Medical Center — Martinez, California (17.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Providence Queen of The Valley — Napa, California (13.9 mi)
· Sponsor: SWOG Cancer Research Network
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente-Vallejo — Vallejo, California (16.1 mi)
· Sponsor: National Cancer Institute (NCI)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Vallejo — Vallejo, California (16.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Sunwise Clinical Research — Walnut Creek, California (24.4 mi)
· Sponsor: Syndeio Biosciences, Inc
Development, Attention, and Inhibition Study
The Ability to Delay Gratification
N/A
Interventional 200 participants sought
Center for Mind and Brain — Davis, California (25.4 mi)
· Sponsor: University of California, Davis